INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 06, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 192,308 | $13.00 | 1,309,638 |
| May 06, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 9,599 | $260.44 | 1,300,039 |
| May 06, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 93,644 | $260.44 | 1,206,395 |
| May 06, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 192,308 | -- | -- |
| May 06, 2013 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,599 | -- | 9,599 |
| Dec 13, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Other acquisition or disposition | -- | -- | 5,791 |
| Dec 13, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Other acquisition or disposition | -- | -- | 5,383 |
| Dec 13, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Other acquisition or disposition | -- | -- | 14,000 |
| Dec 12, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 95,295 | $21.25 | 421,281 |
| Dec 12, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 49,405 | $377.16 | 371,876 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.